Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-29,738
Closed -$2.74M 1159
2022
Q2
$2.74M Sell
29,738
-104,362
-78% -$11.3M 0.01% 720
2022
Q1
$17.6M Sell
134,100
-29,400
-18% -$3.78M 0.05% 385
2021
Q4
$22.7M Sell
163,500
-60,900
-27% -$8.52M 0.06% 337
2021
Q3
$28.3M Buy
224,400
+94,800
+73% +$11.4M 0.08% 278
2021
Q2
$15.9M Sell
129,600
-13,200
-9% -$1.52M 0.04% 402
2021
Q1
$16M Buy
142,800
+126,300
+765% +$13M 0.05% 399
2020
Q4
$1.59M Sell
16,500
-47,700
-74% -$4.17M 0.01% 898
2020
Q3
$4.77M Buy
64,200
+58,100
+952% +$3.89M 0.02% 638
2020
Q2
$360K Sell
6,100
-10,100
-62% -$561K ﹤0.01% 1109
2020
Q1
$725K Sell
16,200
-38,400
-70% -$1.99M ﹤0.01% 914
2019
Q4
$2.73M Buy
+54,600
New +$2.63M 0.01% 756

Other funds holding ENTG

Axa's ENTG Position: Q3 2022 in Review

Axa sold out of Entegris (ENTG) in Q3 2022, closing a stake of 29,738 shares — an estimated $2.74M sold.

Axa first reported a position in ENTG in Q4 2019 and held it in 11 quarters. The position peaked at $28.3M in Q3 2021. 484 funds tracked by Wall St. Rank hold ENTG as of Q3 2022.

  • Axa reported no remaining Entegris position as of Q3 2022 after selling out during the quarter.
  • Axa sold 29,738 Entegris shares in Q3 2022, an estimated $2.74M.
  • Axa first reported a position in Entegris in Q4 2019 and held it in 11 quarters.
  • Axa's Entegris position peaked at $28.3M in Q3 2021.
  • 484 funds tracked by Wall St. Rank held Entegris as of Q3 2022.

Based on Axa's 13F filing for Q3 2022, filed 14 Nov 2022.